Trial Profile
National, Multicenter, Open Label, Phase IV, Before-after Design Study, in Adult Patients With Primary Insomnia to Evaluate Sleep Satisfaction and Psychomotor Performance After 1 Month of Treatment With Zolpidem CR (Ambien CR) in 6 Sites in Argentina.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Jul 2012
Price :
$35
*
At a glance
- Drugs Zolpidem (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- Acronyms MORFEO CR
- Sponsors Sanofi
- 16 Jul 2012 Official title amended as reported by ClinicalTrials.gov.
- 14 Jun 2011 Actual end date (Apr 2011) added as reported by ClinicalTrials.gov.
- 14 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.